Catalysts for Gazyva
14 tracked
Dec 17, 2025
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Oct 17, 2025
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Oct 17, 2025
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Jul 27, 2022
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Jul 12, 2022
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Feb 14, 2022
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Mar 27, 2020
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Nov 16, 2017
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Nov 16, 2017
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Feb 26, 2016
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Sep 23, 2015
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Dec 24, 2014
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Jun 27, 2014
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Nov 1, 2013
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→